Evidence map›Paper›PMID 23918204›Full record

ArticleNeurochemical research2013

Reactive oxygen species from human astrocytes induced functional impairment and oxidative damage.

Wen S Sheng, Shuxian Hu, Amy Feng, R Bryan Rock

Open access · greenAbstract read
In one paragraph

Article in Neurochemical research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 112 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Reactive Astrocytes in Glioma: Emerging Opportunities and Challenges.International journal of molecular sciences · 2025
    Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. A novelFrontiers in cellular neuroscience · 2024
    Article

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Wen S ShengDepartment of Medicine, The Center for Infectious Diseases & Microbiology Translational Research (CIDMTR), University of Minnesota Medical School, Minneapolis, MN, 55455, USA, sheng008@umn.edu.
Shuxian Hu
Amy Feng
R Bryan Rock
University of Minnesota Medical Center · US

Funding

Protective Effects of Cannabinoids in HIV NeuropathogenesisR01DA025525 · NIDA · UNIVERSITY OF MINNESOTA · PI ROCK, ROBERT BRYAN · 2008 to 2012
$1.4M
NIDA NIH HHS DA025525NIDA NIH HHS R01 DA025525
6 · The paper itself

Abstract

Reactive oxygen species (ROS) have been shown to be a contributor to aging and disease. ROS also serve as a trigger switch for signaling cascades leading to corresponding cellular and molecular events. In the central nervous system (CNS), microglial cells are likely the main source of ROS production. However, activated astrocytes also appear to be capable of generating ROS. In this study we investigated ROS production in human astrocytes stimulated with interleukin (IL)-1β and interferon (IFN)-γ and its potential harmful effects. Although IFN-γ alone had no effect, it potentiated IL-1β-induced ROS production in a time-dependent manner. One of the sources of ROS in IL-1β-activated astrocytes was from increased superoxide production in mitochondria accompanied by enhanced manganese superoxide dismutase and inhibited catalase expression. NADPH oxidase (NOX) may also contribute to ROS production as astrocytes express NOX isoforms. Glutamate uptake, which represents one of the most important methods of astrocytes to prevent excitotoxicity, was down-regulated in IL-1β-activated astrocytes, and was further suppressed in the presence of IFN-γ; IFN-γ itself exerted minimal effect. Elevated levels of 8-isoprostane in IL-1β ± IFN-γ-activated human astrocytes indicate downstream lipid peroxidation. Pretreatment with diphenyleneiodonium abolished the IL-1β ± IFN-γ-induced ROS production, restored glutamate uptake function and reduced 8-isoprostane to near control levels suggesting that ROS contributes to the dysfunction of activated astrocytes. These results support the notion that dampening activated human astrocytes to maintain the redox homeostasis is vital to preserve their neuroprotective potential in the CNS.

Indexed as

AstrocytesCells, CulturedDinoprostDrug SynergismGlutamic AcidHumansInterferon-gammaInterleukin-1betaLipid PeroxidationMitochondriaNADPH OxidasesOnium CompoundsOxidation-ReductionReactive Oxygen Species8-epi-prostaglandin F2alphaDinoprostdiphenyleneiodoniumGlutamic AcidIFNG protein, humanInterferon-gammaInterleukin-1betaNADPH OxidasesOnium CompoundsReactive Oxygen Species

Identifiers

PMID23918204
PMCPMC3798006
OpenAlexW2140553664

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.